Allied Energy Corp. (OTCMKTS: AGYP) Soars 18.98% To $0.3558 And Extends Its Green Close Rally. Sees More Gains Ahead

Allied Energy Corp. (OTCMKTS: AGYP) yesterday continued its green rally, soaring 18.98% to $0.3558 in average trading volume. It closed green again last evening and has run counter to oil sector red/green closes, upset by volatility in both the Middle East and Ida-impacted Louisiana. A once 83-cent high close inspires more positive closes in the future. AGYP is having a solid green week — it closed green Monday night at…

Read More >>

Sonnet BioTherapeutics Holdings Inc (SONN) Stock Sees Profit Taking At Higher Level

Stocks which record considerable gains over a short period of time often record declines fairly quickly as well due to profit booking from investors and that is what happened with the Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) stock on Wednesday. Earlier on this week on Tuesday the stock had made a strong move after the company revealed that it had been successful in the completion of the discovery phase of SON…

Read More >>

Ziopharm Oncology (ZIOP) Stock Recovers Sharply After The Recent Fall

One of the stock to have emerged as a major mover on Wednesday was that of Ziopharm Oncology (NASDAQ:ZIOP) as it ended the day with gains of as much as 10%. Considering the magnitude of the rally in the stock yesterday, it is perhaps time for investors to consider taking a closer look at Ziopharm and the reason behind the rally. Prior to yesterday’s rally, the stock had been a…

Read More >>

Meten EdtechX Education Group Ltd (NASDAQ:METX) Stock Soars Again From The Recent Slump

Nowadays many companies are starting their own blockchain and cryptocurrency businesses in order to cash in on the wave. On Wednesday, it was Meten EdtechX Education Group Ltd (NASDAQ:METX) that made such an announcement and it led to a strong rally in its stock. The company announced that it would adapt a new initiative in order to build its own cryptocurrency and blockchain business. After the announcement, the stock soared…

Read More >>

Kelyniam Global Inc. (OTCMKTS:KLYG) Stock Rockets 293%: What’s The Buzz?

Kelyniam Global Inc. (OTCMKTS: KLYG) jumped 293% last week after announcing its Q2 2021 financial results.  The company reported total revenues of $1.224 million, a 3.25% sales revenue decline from $1.27 million a year ago. In addition, Kelyniam’s operating income was $47,167 relative to $181,395 a year ago, while the company reported a net income of $5,544 relative to $184,567 for the first six months of 2020. CEO Ross Bjella…

Read More >>

LuoKung Technology Corp (NASDAQ:LKCO) Stock Soars 26% in a Month: Here is Why

LuoKung Technology Corp (NASDAQ: LKCO) is up 26% in a month. The company has issued an open letter to its shareholders from the CEO and Chairman Xuesong Song about its corporate strategy and 2021 outlook and beyond. Song said that the company had made considerable progress in recent times, and most recently its completed the acquisition of eMapgo Technologies (Beijing) Co. Ltd. He said that the company is leading in…

Read More >>

Caladrius Biosciences Inc. (NASDAQ:CLBS) Stock Sees Selling Pressure At Higher Level

Caladrius Biosciences Inc. (NASDAQ: CLBS) fell 2.3% after announcing Dr. Kristen K. Buck’s appointment as the company’s Chief Medical Officer (CMO). Buck is joining the company from ICON plc, where she served in the position of CMO. She represented ICON’s position on major scientific, medical governance, and ethical matters and offered oversight and guidance to scientific and medical groups. Before that, she worked at Optum Insights as an SVP and…

Read More >>

Brickell Biotech Inc. (NASDAQ:BBI) Stock Picks Up Momentum: Jumps 7% in a Week

Brickell Biotech Inc. (NASDAQ: BBI) jumped 7% in a week. The company and Voronoi Inc. have signed a definitive agreement with Voronoi Inc. for exclusive global rights to treatment developed from the novel DYRK1A inhibitor platform. Notably, the DYRK1A inhibitor platform seeks to restore the immune balance of individuals with dysregulated immune systems. As a result, the inhibitors offer potential in a wide range of inflammatory and autoimmune diseases. Brickell’s…

Read More >>
x